Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Safety”

5,678 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,678 results

Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20
Not applicableStudy completedNCT01251042
What this trial is testing

Comparison Between Return and Wastage of Your Own Blood, Collected During Spinal Surgery, for Verification of Safety When Returning Blood

Who this might be right for
Spinal Surgery
Wellspect HealthCare 51
Early research (Phase 1)Study completedNCT00001020
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT00902824
What this trial is testing

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 32
Very early researchStudy completedNCT02431273
What this trial is testing

Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women

Who this might be right for
Human Immunodeficiency Virus (HIV) Prophylaxis
Auritec Pharmaceuticals 10
Large-scale testing (Phase 3)Study completedNCT01568580
What this trial is testing

Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A

Who this might be right for
Hemophilia A
Green Cross Corporation 71
Post-approval studies (Phase 4)Study completedNCT03253562
What this trial is testing

Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

Who this might be right for
Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients
MTI University 120
Not applicableStudy completedNCT00665561
What this trial is testing

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Who this might be right for
Human Immunodeficiency Virus
ViiV Healthcare 2,500
Post-approval studies (Phase 4)Study completedNCT01138215
What this trial is testing

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

Who this might be right for
HIV InfectionsVaricella-zoster Virus
The HIV Netherlands Australia Thailand Research Collaboration 60
Early research (Phase 1)Study completedNCT01634568
What this trial is testing

A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

Who this might be right for
Parkinson's Disease
Vernalis (R&D) Ltd 49
Testing effectiveness (Phase 2)Study completedNCT01605513
What this trial is testing

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

Who this might be right for
Hepatitis C Virus
The First Hospital of Jilin University 80
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT00333424
What this trial is testing

Thai Prophylactic HIV Vaccine Phase I Study

Who this might be right for
HIV
Kirby Institute 8
Post-approval studies (Phase 4)Study completedNCT03258710
What this trial is testing

Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 75
Testing effectiveness (Phase 2)UnknownNCT00003942
What this trial is testing

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Systemix 15
Early research (Phase 1)Study completedNCT03463369
What this trial is testing

A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed

Who this might be right for
Hepatitis B, Chronic
Janssen Sciences Ireland UC 30
Large-scale testing (Phase 3)Study completedNCT00157105
What this trial is testing

Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery

Who this might be right for
Hemophilia A
Baxalta now part of Shire 59
Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Early research (Phase 1)Study completedNCT05781542
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 46
Large-scale testing (Phase 3)Looking for participantsNCT06833983
What this trial is testing

To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A

Who this might be right for
Hemophilia A
Gritgen Therapeutics Co., Ltd. 50
Next Page